Delivery Order SPE2DB20D1100-SPE2DB24FC7F4
Award Date
7/12/24
Potential Completion Date
8/2/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 4 MG TABLET 100S. The $1,421.82 fixed-price contract has a completion date of June 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENVARSUS XR 4 MG TABLET 100S. The order, valued at $1,615.33, has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,621.48, is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The delivery order has a completion date of February 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed-price delivery order contract worth $2,026.85 by the Defense Logistics Agency (DLA) to provide ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of March 19, 2024 and was awarded on February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA valued at up to $999,999,999.00, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,423.90, is for the provision of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 3, 2025 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of ENVARSUS XR 4 MG TABLET 100S, a specialty pharmaceutical product, with a potential value of $6,461.32 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 1 MG TABLET 30S. The contract has a ceiling value of $1,465.68 and is a firm-fixed price contract with a period of performance through September 27, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $2,026.85 and a completion date of May 13, 2024. Amerisourcebergen Drug Corp, a subsidiary of the larger Amerisourcebergen Corporation, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ENVARSUS XR 1 MG TABLET 30S. The potential value of the contract is $5,138.64. The contract has a completion date of February 13, 2024 and was awarded on January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,221.40, is for the supply of the medication ENVARSUS XR 1 MG TABLET 30S. It is a firm fixed-price contract with a completion date of June 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains several Indefinite Delivery...